Dideoxyverticillin A potently inhibits the tyrosine kinase activity of the epidermal growth factor receptor ( median inhibitory concentration = 0.14 nM ) , exhibits antiangiogenic activity .
Dideoxyverticillin A potently has efficacy against several cancer cell lines .
Dideoxyverticillin A potently inhibits the tyrosine kinase activity of the epidermal growth factor receptor ( median inhibitory concentration = 0.14 nM ) , exhibits antiangiogenic activity , and has efficacy against several cancer cell lines .